A
Araz Sabzevari
Researcher at Tehran University of Medical Sciences
Publications - 21
Citations - 701
Araz Sabzevari is an academic researcher from Tehran University of Medical Sciences. The author has contributed to research in topics: PLGA & Differential scanning calorimetry. The author has an hindex of 9, co-authored 21 publications receiving 442 citations. Previous affiliations of Araz Sabzevari include Tabriz University of Medical Sciences & Noor Eye Hospital.
Papers
More filters
Journal ArticleDOI
Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management.
Abubakar Umar Anka,Mohammed Ibrahim Tahir,Sharafudeen Dahiru Abubakar,Mohamed Alsabbagh,Zeineb Zian,Haleh Hamedifar,Araz Sabzevari,Gholamreza Azizi +7 more
TL;DR: Treatment approaches to COVID‐19 treatment involve the use of antiviral agents that interfere with the SARS‐CoV‐2 lifecycle to prevent further viral replication and utilizing immunomodulators to dampen the immune system in order to prevent cytokine storm and tissue damage.
Journal ArticleDOI
Preparation and physicochemical characterization of naproxen-PLGA nanoparticles.
Yousef Javadzadeh,Fatemeh Ahadi,Soodabeh Davaran,Ghobad Mohammadi,Ghobad Mohammadi,Araz Sabzevari,Khosro Adibkia +6 more
TL;DR: In this article, the physicochemical characteristics of nanoparticles were studied applying particle size analysis, differential scanning calorimetry, X-ray crystallography, Fourier transform infrared spectroscopy and scanning electron microscopy.
Journal ArticleDOI
Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment.
Reyhaneh Varshochian,Mohammad Riazi-Esfahani,Mahmood Jeddi-Tehrani,Ahmad-Reza Mahmoudi,Sara Aghazadeh,Mirgholamreza Mahbod,Morteza Movassat,Fatemeh Atyabi,Araz Sabzevari,Rassoul Dinarvand +9 more
TL;DR: In this study albuminated-PLGA-NPs containing bevacizumab were prepared and studied intended for reducing the number of injections and confirmed the nanoparticles persistence in ocular tissues during the test span.
Journal ArticleDOI
The protective effect of albumin on bevacizumab activity and stability in PLGA nanoparticles intended for retinal and choroidal neovascularization treatments.
Reyhaneh Varshochian,Mahmood Jeddi-Tehrani,Ahmad Reza Mahmoudi,Mohammad Reza Khoshayand,Fatemeh Atyabi,Araz Sabzevari,Mohammad Riazi Esfahani,Rassoul Dinarvand +7 more
TL;DR: Results revealed that the protein interfacial adsorption is the foremost destabilizing factor in the double emulsion method and incorporation of appropriate concentrations of albumin could protect bevacizumab against entrapment stress.
Journal ArticleDOI
Polymeric triamcinolone acetonide nanoparticles as a new alternative in the treatment of uveitis: in vitro and in vivo studies.
Araz Sabzevari,Khosro Adibkia,Hassan Hashemi,Hassan Hashemi,Alireza Hedayatfar,Navid Mohsenzadeh,Navid Mohsenzadeh,Fatemeh Atyabi,Mohammad Hossein Ghahremani,Rassoul Dinarvand +9 more
TL;DR: Sustain release biodegradable TA nanoparticles are potential new topical treatment options which can provide better patient compliance and be used in the treatment of endotoxin-induced uveitis.